Yes, a number of new chemical entities have been approved as pharmaceutical products in both the United States and in the European Union. An in-vivo study demonstrates that Capsugel® Vcaps® plus capsules are equivalent to gelatin in terms of human pharmacokinetics profile. Given the unique properties of Capsugel® Vcaps® Plus there is a growing interest from pharmaceutical companies in utilizing this capsule as an alternative to gelatin.